Pediatric pressure ulcer prevalence: a multicenter, cross-sectional, point prevalence study in Switzerland 

Anna-Barbara Schlüer1, Ruud J Halfens, Jos M G A Schols

  • 1Section of Nursing Science, Children's Research Center, Children's University Hospital Zurich, Zurich, Switzerland. Barbara.Schlueer@kispi.uzh.ch

Insights

Pediatric pressure ulcers (PUs) affect 35% of hospitalized children, particularly those in intensive care or neonatology. Key risk factors include medical devices, young age, and longer hospital stays, necessitating targeted prevention strategies.

Area of Science:

  • Pediatric Nursing
  • Wound Care
  • Hospital Epidemiology

Background:

  • Pressure ulcers (PUs) are a significant concern in hospitalized pediatric populations.
  • Limited data exists on PU risk factors, prevalence, and incidence in children.

Purpose of the Study:

  • To determine the prevalence of PUs in hospitalized children (0-18 years).
  • To identify risk factors associated with PU development in pediatric patients.

Main Methods:

  • A 1-day cross-sectional study was conducted in 14 Swiss pediatric hospitals.
  • Systematic skin inspection and assessment using a standardized instrument by trained raters.
  • 412 hospitalized children participated, representing 75% of the target population.

Main Results:

  • Overall PU prevalence was 35%, with 80% being category 1.
  • Highest prevalence observed in Pediatric Intensive Care Units (PICU) (44%) and Neonatology (43%).
  • Significant risk factors included medical devices, age <1 year, longer length of stay, and low Braden Scale scores (P <0.05).

Conclusions:

  • Pediatric PU prevalence is higher than anticipated, highlighting the need for preventative interventions.
  • Category 1 PUs are common, indicating opportunities for early prevention.
  • PICU patients, neonates, and those with specific risk factors require focused attention for PU prevention.

Related Concept Videos

Peptic Ulcer Disease III: Clinical Manifestations and Complications01:25

Peptic Ulcer Disease III: Clinical Manifestations and Complications

Duodenal UlcersDuodenal ulcers are the most common form of peptic ulcer disease, presenting with chronic, intermittent epigastric pain. Pain typically appears 2–3 hours after meals, especially when the stomach is empty, often waking patients at night. It is characteristically relieved by food or antacids (“pain–food–relief”). Some patients remain asymptomatic until complications like bleeding or perforation emerge, particularly with NSAID or anticoagulant use.Gastric UlcersGastric ulcers share...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Peptic Ulcer01:27

Peptic Ulcer

Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the mucus...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Peptic Ulcer Disease V: Surgical Management and Nursing Care01:25

Peptic Ulcer Disease V: Surgical Management and Nursing Care

Surgical management and nursing care are crucial in treating Peptic Ulcer Disease (PUD). Here is an organized and enhanced overview of the surgical interventions and the associated nursing care for PUD:
Surgical Interventions for Peptic Ulcer Disease